Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of remifentanil infusion versus hydralazine + propranolol for controlled hypotension in rhinoplasty
IRCT2015101522173N2Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Sep 2015
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in hypertension (HTN) comparing Remifentanil infusion with Hydralazine + propranolol single dose (2 arms). Primary endpoint: Achievement of controlled hypotension. Started Sep 2015; status: completed.
02
Drugs
remifentanilhydralazinepropranolol
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on IRCT2015101522173N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2015101522173N2.